SCHEMBL11869329

SCHEMBL11869329

C1=CC2=NC1=CC1=NC(=C(c3ccccc3)C3=NC(=CC4=NC(=C2)C=C4)C=C3c2ccccc2)C(c2ccccc2)=C1c1ccccc1.[Ag]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11018793 0.97 — —
SCHEMBL16440032 0.97 — —
SCHEMBL28518152 0.97 — —
Hydrochloric Acid SCHEMBL3190944 0.97 — —
SCHEMBL37860 0.97 — —
SCHEMBL23704657 0.97 — —
SCHEMBL7165138 0.97 — —
SCHEMBL28599777 0.97 — —
SCHEMBL613742 0.97 — —
SCHEMBL28026975 0.97 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112331787-B Application of metal tetraphenylporphyrin complex in electron transport material, quantum dot light-emitting device and preparation method thereof, and light-emitting device 广东聚华印刷显示技术有限公司 2022-07-12 — — CN claimed
CN-112331787-A Application of metal tetraphenylporphyrin complex in electron transport material, quantum dot light-emitting device and preparation method thereof, and light-emitting device 广东聚华印刷显示技术有限公司 2021-02-05 — — CN claimed
US-3935031-A PORPHYRIN COMPOUND NEW ENGLAND INSTITUTE, INC. (US) 1976-01-27 — — US claimed
CN-118946553-A SARM1 inhibitor compound, pharmaceutical composition comprising the same, and preparation method and use thereof 深圳众格生物科技有限公司 2024-11-12 — — CN disclosed
CN-111499684-B Anti-CD 70 antibody drug conjugates AMBRX公司 2024-10-22 — — CN disclosed
CN-116514899-A Prostate specific membrane antigen-antibody drug conjugates AMBRX公司 2023-08-01 — — CN disclosed
CN-108727466-B Prostate specific membrane antigen-antibody drug conjugates AMBRX公司 2023-04-28 — — CN disclosed
CN-112331787-B Application of metal tetraphenylporphyrin complex in electron transport material, quantum dot light-emitting device and preparation method thereof, and light-emitting device 广东聚华印刷显示技术有限公司 2022-07-12 — — CN disclosed
CN-108779078-B Inhibitors and probes of kinases and uses thereof 北京大学深圳研究生院 2021-12-31 — — CN disclosed
CN-113527414-A Compositions containing non-natural amino acid linked dolastatin derivatives, methods involving the dolastatin derivatives, and uses thereof AMBRX公司 2021-10-22 — — CN disclosed
CN-110078788-B Dolastatin derivatives containing unnatural amino acid linkages AMBRX 公司 2021-08-06 — — CN disclosed
CN-108047142-B Heteroaryl compounds and uses thereof 西建卡尔有限责任公司 2021-08-03 — — CN disclosed
CN-112331787-A Application of metal tetraphenylporphyrin complex in electron transport material, quantum dot light-emitting device and preparation method thereof, and light-emitting device 广东聚华印刷显示技术有限公司 2021-02-05 — — CN disclosed
CN-111793068-A Heteroaryl compounds and uses thereof 西建卡尔有限责任公司 2020-10-20 — — CN disclosed
CN-105307657-B Heteroaryl compounds and uses thereof 西建卡尔有限责任公司 2020-07-10 — — CN disclosed
US-20160279127-A1 HETEROARYL COMPOUNDS AND USES THEREOF CELGENE AVILOMICS RESEARCH, INC. 2016-09-29 — — US disclosed
CN-105307657-A Heteroaryl compounds and uses thereof CELGENE AVILOMICS RES INC 2016-02-03 — — CN disclosed
US-3935031-A PORPHYRIN COMPOUND NEW ENGLAND INSTITUTE, INC. (US) 1976-01-27 — — US disclosed
Send feedback